Condition
Stem Cell Mobilization
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Unknown2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05409547Phase 4Unknown
A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF
NCT03388073Not ApplicableUnknownPrimary
Evaluation of Plant-based Nutritional Products on Stem Cells
NCT01164345Phase 2Completed
Mozobil for Autologous Stem Cell Mobilization
Showing all 3 trials